Home Drug Codes J Codes J9150 · DAUNORUBICIN HCL
Updated July 1st, 2026

DAUNORUBICIN HCL J Code: J9150

Injection, daunorubicin, 10 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9150, effective October 1, 2026: $26.912 per HCPCS billing unit, down 6.6% from $28.81. From CMS's final file.

?
Medicare Payment Limit ?
$28.81
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
10
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, daunorubicin, 10 mg
HCPCS Added Date January 1, 1986
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection | Injection, Solution

About DAUNORUBICIN HCL

Daunorubicin HCL is a medication aligned to the HCPCS J Code: J9150 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: Daunorubicin is used to treat leukemia and other cancers. It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 10 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00143-9550-01 Daunorubicin Hydrochloride Hikma Pharmaceuticals USA Inc. 5 50 MG / 10 ML
00143-9551-10 Daunorubicin Hydrochloride Hikma Pharmaceuticals USA Inc. 20 20 MG / 4 ML
42658-0019-01 Daunorubicin Hydrochloride Hisun Pharmaceuticals USA, Inc. 5 50 MG / 10 ML
42658-0021-01 Daunorubicin Hydrochloride Hisun Pharmaceuticals USA, Inc. 2 20 MG / 4 ML
71288-0182-05 daunorubicin hydrochloride Meitheal Pharmaceuticals Inc. 20 20 MG / 4 ML
•••••-••••-•• Log in to view DAUNORUBICIN HCL
DAUNORUBICIN HCL
DAUNORUBICIN HCL
Login to view 5 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

DAUNORUBICIN HCL Pricing & Reimbursement

J9150 Private Payer Reimbursement
$27.04 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

DAUNORUBICIN HCL CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Daunorubicin HCL (J9150) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

DAUNORUBICIN HCL Medically Unlikely Edits (MUE)

The most billing units of J9150 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mg.

Practitioner Office & Hospital Outpatient
12 units / day
= 120 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

DAUNORUBICIN HCL Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute Lymphocytic Leukemia Acute Nonlymphocytic Leukemia
Drug Class
Anthracycline Topoisomerase Inhibitor [EPC]Anthracyclines [CS]Topoisomerase Inhibitors [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Daunorubicin Hcl billing and coding guide?
We have not yet identified a manufacturer source of Daunorubicin Hcl billing and coding information.
Are there any available Daunorubicin Hcl patient assistance programs?
Our team did not identify a source for Daunorubicin Hcl patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Daunorubicin Hcl prescribing information?
DAUNORUBICIN HCL prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Daunorubicin Hcl side effect information?
Our team has not yet identified a source of side effects information for DAUNORUBICIN HCL. Please check back in a few weeks.
Does billing DAUNORUBICIN HCL require JZ/JW wastage modifiers?
CMS has identified DAUNORUBICIN HCL(J9150) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.